COMPARATIVE STUDY OF FUNDING OPPORTUNITY FOR AN EXPENSIVE INNOVATIVE OUTPATIENT TREATMENT IN EMERGING MARKETS
Author(s)
Kornfeld M1, Belgaied W2, Kornfeld Å1, Toumi M3
1Creativ-Ceutical, Paris, France, 2Creativ-Ceutical, Tunis, Tunisia, 3Aix-Marseille University, Marseille, France
OBJECTIVES: To evaluate the funding opportunity for an innovative Hepatitis B treatment in six emerging markets with differently advanced public funding systems: South Korea, Turkey, Indonesia, Philippines, Thailand and Nigeria. METHODS:
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PIN75
Topic
Health Policy & Regulatory
Topic Subcategory
Reimbursement & Access Policy
Disease
Infectious Disease (non-vaccine)
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now